These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31400703)

  • 1. Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.
    Schuster J; Fatima A; Sobol M; Norradin FH; Laan L; Dahl N
    Stem Cell Res; 2019 Aug; 39():101523. PubMed ID: 31400703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a human iPSC line (UUIGPi015-A) from a patient with Dravet syndrome and a 2.9 Mb deletion spanning SCN1A on chromosome 2.
    Schuster J; de Guidi C; Tripathi R; Klar J; Dahl N
    Stem Cell Res; 2022 Apr; 60():102712. PubMed ID: 35203050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model.
    Zayat V; Kuczynska Z; Liput M; Metin E; Rzonca-Niewczas S; Smyk M; Mazurczak T; Goszczanska-Ciuchta A; Leszczynski P; Hoffman-Zacharska D; Buzanska L
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.
    Maeda H; Chiyonobu T; Yoshida M; Yamashita S; Zuiki M; Kidowaki S; Isoda K; Yamakawa K; Morimoto M; Nakahata T; Saito MK; Hosoi H
    J Hum Genet; 2016 Jun; 61(6):565-9. PubMed ID: 26841829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line.
    Shan W; Yang X; Ren Q; Wang Q
    Stem Cell Res; 2021 Aug; 55():102452. PubMed ID: 34247112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene.
    Arribas-Carreira L; Bravo-Alonso I; López-Márquez A; Alonso-Barroso E; Briso-Montiano Á; Arroyo I; Ugarte M; Pérez B; Pérez-Cerdá C; Rodríguez-Pombo P; Richard E
    Stem Cell Res; 2019 Aug; 39():101503. PubMed ID: 31349202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.
    Schuster J; Laan L; Klar J; Jin Z; Huss M; Korol S; Noraddin FH; Sobol M; Birnir B; Dahl N
    Neurobiol Dis; 2019 Dec; 132():104583. PubMed ID: 31445158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene.
    Tanaka Y; Higurashi N; Shirasu N; Yasunaga S; Moreira KM; Okano H; Hirose S
    Stem Cell Res; 2018 Aug; 31():11-15. PubMed ID: 29981888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of D1-1 TALEN isogenic control cell line from Dravet syndrome patient iPSCs using TALEN-mediated editing of the SCN1A gene.
    Tanaka Y; Sone T; Higurashi N; Sakuma T; Suzuki S; Ishikawa M; Yamamoto T; Mitsui J; Tsuji H; Okano H; Hirose S
    Stem Cell Res; 2018 Apr; 28():100-104. PubMed ID: 29453127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.
    Liu Y; Lopez-Santiago LF; Yuan Y; Jones JM; Zhang H; O'Malley HA; Patino GA; O'Brien JE; Rusconi R; Gupta A; Thompson RC; Natowicz MR; Meisler MH; Isom LL; Parent JM
    Ann Neurol; 2013 Jul; 74(1):128-39. PubMed ID: 23821540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
    Shao Z; Cevallos RR; Hu K
    Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
    Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
    Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
    Sun Y; Paşca SP; Portmann T; Goold C; Worringer KA; Guan W; Chan KC; Gai H; Vogt D; Chen YJ; Mao R; Chan K; Rubenstein JL; Madison DV; Hallmayer J; Froehlich-Santino WM; Bernstein JA; Dolmetsch RE
    Elife; 2016 Jul; 5():. PubMed ID: 27458797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
    Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
    Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
    Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
    Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene.
    Zhao H; He L; Li S; Huang H; Tang F; Han X; Lin Z; Tian C; Huang R; Zhou P; Huang J; Deng S; Li Z
    Stem Cell Res; 2020 Jul; 46():101864. PubMed ID: 32544858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.